aeruginosa infection on patient outcomes remains ... variable mechanism(s) of resistance, retrospective study design and publication bias. In addition to intrinsic biofitness and/or virulence ...
It demonstrates the surprising level of resistance to cleaning agents of multidrug-resistant Pseudomonas aeruginosa-; a pathogen of particular concern in hospital settings. The study also ...
TAXIS Pharmaceuticals is developing first-in-class anti-resistance drugs to help re-engage widely prescribed but resistance-prone generic antibiotics to treat patients with multidrug-resistant ...
It demonstrates the surprising level of resistance to cleaning agents of multidrug-resistant Pseudomonas aeruginosa-- a pathogen of particular concern in hospital settings. The study also ...
Multidrug-resistant organisms are an established and growing worldwide public health problem, since few therapeutic options remain available. MRSA is the leading Gram-positive organism that has ...
I have been working on the antibiotic resistance mechanism and the cell membrane transporter in Pseudomonas aeruginosa and Enterobacter cloacae for more than 10 years. Currently we are focusing on the ...